Aura Biosciences, Inc.
AURA
$5.38
-$0.14-2.54%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.47M | 6.20M | 5.88M | 5.26M | 4.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.81M | 23.23M | 22.76M | 22.31M | 24.78M |
| Operating Income | -27.81M | -23.23M | -22.76M | -22.31M | -24.78M |
| Income Before Tax | -25.81M | -21.00M | -20.34M | -19.66M | -21.99M |
| Income Tax Expenses | 24.00K | 43.00K | -- | 46.00K | 137.00K |
| Earnings from Continuing Operations | -25.83M | -21.04M | -20.34M | -19.71M | -22.13M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.83M | -21.04M | -20.34M | -19.71M | -22.13M |
| EBIT | -27.81M | -23.23M | -22.76M | -22.31M | -24.78M |
| EBITDA | -27.52M | -22.92M | -22.45M | -22.01M | -24.46M |
| EPS Basic | -0.52 | -0.42 | -0.41 | -0.40 | -0.50 |
| Normalized Basic EPS | -0.32 | -0.26 | -0.26 | -0.25 | -0.31 |
| EPS Diluted | -0.52 | -0.42 | -0.41 | -0.40 | -0.50 |
| Normalized Diluted EPS | -0.32 | -0.26 | -0.26 | -0.25 | -0.31 |
| Average Basic Shares Outstanding | 49.94M | 49.66M | 49.55M | 49.45M | 44.65M |
| Average Diluted Shares Outstanding | 49.94M | 49.66M | 49.55M | 49.45M | 44.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |